BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  House Subcommittee Interrogates Emergent Execs Over Vaccine and Money Mess

  The House Select Subcommittee on the Coronavirus Crisis questioned executives from Emergent BioSolutions as part of a congressional probe.

  May 20, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  Forbes’ “30 Under 30" List Highlights the Future Leaders of Biotech

  Forbes highlights its “30 Under 30" list who are beginning to make their mark in the biopharma and healthcare industries.

  May 20, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  BioSpace Movers & Shakers, May 21

  Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.

  May 20, 2021

   · 

  10 min read

   · 

  Alex Keown
• 

  Drug Development

  Global Roundup: Russia-Developed RA Drug Shows Significant Promise in Phase III Study

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  May 20, 2021

   · 

  6 min read

   · 

  Alex Keown
• 

  Drug Development

  Voyager Therapeutics CEO and CMO Resign as Company Undergoes Strategic Shift

  Shares of Voyager Therapeutics fell in aftermarket trading after its CEO and CMO announced plans to depart the company following clinical setbacks with a Parkinson’s disease program.

  May 20, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Lilly’s Tirzepatide Significantly Reduces A1C, Body Weight Versus Insulin Glargine

  Eli Lilly’s SURPASS-4 trial program shows tirzepatide, significantly reduced blood glucose levels and body weight better than insulin glargine in adult patients with type 2 diabetes.

  May 20, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Drug Development

  Precision Medicine Study Points to Promising New Approach in Alzheimer’s

  The team has taken a fundamentally new approach to Alzheimer’s, and it centers around the hypothesis that there are multiple drivers causing the disease.

  May 20, 2021

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Genetown

  Research Roundup: Explaining Rare Immune Response in Children with COVID-19 and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  May 20, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca

  Companies have already begun their announcements of new clinical studies for various treatment settings in preparation for ASCO 2021.

  May 20, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Centivax Drives Next-Generation COVID-19 Antibody into the Clinic

  “The virus will not be eradicated through vaccination alone. That means... we need our medicines. That was a failure of 2020 that doesn’t get enough emphasis,” Jake Glanville, chief executive officer of Bay Area-based Centivax, told BioSpace in an interview.

  May 20, 2021

   · 

  3 min read

   · 

  Alex Keown